E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 2/25/2016 in the Prospect News Structured Products Daily.

New Issue: RBC prices $2 million of trigger phoenix autocallables linked to biotech, energy ETFs

By Wendy Van Sickle

Columbus, Ohio, Feb. 25 – Royal Bank of Canada priced $2 million of trigger phoenix autocallable notes due March 1, 2017 linked to the lesser performing of the SPDR S&P Biotech exchange-traded fund and the Energy Select Sector SPDR fund, according to a 424B2 filing with the Securities and Exchange Commission.

Each quarter, the notes will pay a contingent coupon at an annual rate of 16% if each fund closes at or above its trigger level, 60% of its initial share price, on the observation date for that quarter.

The notes will be called at par if each fund closes at or above its initial share price on any quarterly call observation date.

If the notes are not called and each fund finishes at or above its trigger level, the payout at maturity will be par plus the final contingent coupon. Otherwise, investors will be exposed to the decline of the lesser-performing fund.

RBC Capital Markets LLC is the agent.

Issuer:Royal Bank of Canada
Issue:Trigger phoenix autocallable notes
Underlying funds:SPDR S&P Biotech ETF and Energy Select Sector SPDR fund
Amount:$1,994,000
Maturity:March 1, 2017
Coupon:16% per year, payable quarterly if each fund closes at or above trigger price on observation date for that quarter
Price:Par
Payout at maturity:Par plus contingent coupon if each fund finishes at or above trigger price; otherwise, exposure to decline of lesser-performing fund
Call:At par plus contingent coupon if each fund closes at or above initial share price on any quarterly observation date
Initial prices:$48.76 for SPDR S&P Biotech, $56.87 for Energy Select Sector SPDR
Trigger levels:$29.26 for SPDR S&P Biotech, $34.12 for Energy Select Sector SPDR; 60% of initial share price
Pricing date:Feb. 24
Settlement date:Feb. 29
Underwriters:RBC Capital Markets, LLC
Fees:1.75%
Cusip:78012KLP0

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.